Alpa Laboratories Limited
Symbol: ALPA.BO
BSE
90.5
INRDzisiejsza cena rynkowa
10.3959
Wskaźnik P/E
-0.9674
Wskaźnik PEG
1.90B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Alpa Laboratories Limited (ALPA-BO) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 808.4 | 702.7 | 424.9 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | 720.3 | 687 | 406.9 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 501.4 | 430.8 | 381.4 | |||||||||||||||
balance-sheet.row.inventory | 0 | 126.4 | 154.6 | 165.6 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 81.6 | 72.7 | 107.8 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1491.2 | 1380.1 | 1210.9 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 69.6 | 92.2 | 87.3 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.8 | 1 | 0.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 96.5 | 61.5 | 104.9 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 9.3 | 0 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 14.5 | 8.3 | 0 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 181.4 | 172.3 | 192.8 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 150.6 | 149.2 | 247.3 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 15.3 | 37.2 | 1.8 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 22.8 | 25.7 | 2.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
Deferred Revenue Non Current | 0 | 0 | -25.7 | -2.2 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 73.4 | 67.4 | 38.8 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7.8 | 21.2 | 0.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 326.9 | 335.1 | 327.3 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 210.4 | 210.4 | 210.4 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | 585.8 | 457.3 | 316.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 760 | 760 | 760 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -210.4 | -210.4 | -210.4 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1672.7 | 1552.4 | 1403.7 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 1345.8 | 1217.3 | 1076.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 77.7 | 74.7 | 101.5 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 23 | 58.5 | 1.9 | |||||||||||||||
balance-sheet.row.net-debt | 0 | -65.1 | 42.7 | -16.1 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 156.8 | 195.6 | 107.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -8 | 14.5 | -103.4 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -66.4 | -0.3 | -185 | |||||||||||||||
cash-flows.row.inventory | 0 | 28.2 | 11 | -40.1 | |||||||||||||||
cash-flows.row.account-payables | 0 | 19.8 | -78.9 | 127.2 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 10.3 | 82.8 | -5.5 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -73 | -127.3 | -33.8 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -5 | 42.3 | 3.7 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.3 | -191.8 | 7.9 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 12.3 | 15.4 | 79.1 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 25.5 | -0.1 | 0.1 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 21.3 | -156.1 | 58.6 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -35.4 | -21.2 | -1.8 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2.5 | 75.6 | 3.7 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -37.9 | 54.4 | 1.9 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -0.1 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 72.4 | -2.3 | 43.4 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 88.1 | 15.8 | 105.1 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 15.8 | 18 | 61.7 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 89 | 99.4 | -17 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -11.3 | -21.9 | -32.2 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | 77.8 | 77.5 | -49.2 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 924.1 | 1105.1 | 964.1 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 615 | 760.9 | 647.6 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 309.1 | 344.3 | 316.6 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 235.5 | 248.8 | 219.4 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 850.5 | 1009.7 | 867 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 10.4 | 14.6 | 6.5 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 28.8 | 1.5 | 0.5 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 81 | 101.1 | 41.7 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 0.8 | 1.1 | 0.3 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 13.3 | 16.6 | 12.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | 67.5 | 79.6 | 69 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | 158.9 | 195.6 | 107.9 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 33.1 | 54.7 | 35.4 | |||||||||||||||
income-statement-row.row.net-income | 0 | 125.8 | 140.9 | 72.5 |
Często zadawane pytania
Ile wynosi Alpa Laboratories Limited (ALPA.BO) aktywów ogółem?
Alpa Laboratories Limited (ALPA.BO) całkowite aktywa to 1672699000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.350.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 7.032.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.157.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.135.
Co to jest Alpa Laboratories Limited (ALPA.BO) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 125828000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 23040000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 235520000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.